Greater uptake, an alternative reimbursement methodology needed to realize cost-saving potential of oncology biosimilars in the United States-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Greater uptake, an alternative reimbursement methodology needed to realize cost-saving potential of oncology biosimilars in the United States

Published:2021-12 Issue:12 Volume:27 Page:1642-1651
ISSN:2376-0540
Container-title:Journal of Managed Care & Specialty Pharmacy
language:en
Short-container-title:JMCP

Author:

Yang Jingyan¹,Carioto Jennifer²,Pyenson Bruce²,Smith Rebecca²,Jacobson Nathaniel²,Pittinger Sean²,Shelbaya Ahmed³

Affiliation:

1. Patient Health and Impact (PHI), Pfizer Inc., New York, NY, and Institute for Social and Economic Research and Policy (ISERP), Columbia University, New York, NY.

2. Milliman Inc., New York, NY.

3. Patient Health and Impact (PHI), Pfizer Inc., New York, NY, and Mailman School of Public Health, Columbia University, New York, NY.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stakeholder perspectives on the sustainability of the United States biosimilars market;Journal of Managed Care & Specialty Pharmacy;2024-07-16

2. A primer on brand-name prescription drug reimbursement in the United States;Journal of Managed Care & Specialty Pharmacy;2024-01-01

3. Real-world cost–effectiveness of primary prophylaxis with G-CSF biosimilars in patients at intermediate/high risk of febrile neutropenia;Future Oncology;2022-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP